In a national screening program for cervical cancer in India, which of the following is the most common reason for failure to detect precancerous lesions in the target population?

Explanation

## Barriers to Effective Cervical Cancer Screening in India ### The Screening Paradox **Key Point:** A screening test with excellent sensitivity and specificity will fail to detect disease if it does not reach the target population. The most common reason for failure in real-world screening programs is **inadequate coverage** and **poor compliance**, not test characteristics. ### Why Coverage and Compliance Matter Most | Component | Impact on Program Success | Indian Context | |-----------|---------------------------|----------------| | **Test sensitivity** | Determines detection rate among screened | Pap smear ~90% sensitivity; adequate | | **Test specificity** | Determines false-positive rate | Pap smear ~99% specificity; adequate | | **Coverage** | % of eligible population actually screened | **India: ~5–10% in many states** | | **Compliance** | % of screened individuals who complete follow-up | **Low in rural/low-income populations** | | **Cost accessibility** | Determines who can afford screening | Major barrier in India | ### The Real-World Problem 1. **Inadequate Coverage**: In India, cervical cancer screening programs have reached only a small fraction of eligible women (15–49 years). Many women in rural areas, low-income groups, and marginalized communities do not access screening. 2. **Poor Compliance**: Even when screening is offered, compliance with: - Initial screening attendance - Follow-up for abnormal results - Colposcopy and biopsy referrals - Treatment of precancerous lesions remains low due to: - Lack of awareness - Cultural barriers - Distance to health centers - Competing health priorities **High-Yield:** A screening program can only detect disease in individuals who actually **participate**. The best test is useless if it never reaches the population. ### Clinical Pearl India's cervical cancer burden persists not because Pap smear or HPV testing is insensitive, but because screening programs have not achieved adequate **population coverage**. The WHO recommends ≥70% coverage for meaningful impact on cancer incidence. ### Mnemonic for Screening Program Success **CAST**: **C**overage, **A**ccuracy (sensitivity/specificity), **S**ensitivity of follow-up, **T**reatment of detected lesions. Coverage is the first and most critical element.